Literature DB >> 34610749

Intra-Articular Adeno-Associated Virus-Mediated Proteoglycan 4 Gene Therapy for Preventing Posttraumatic Osteoarthritis.

Dongrim Seol1,2, Hyeong Hun Choe1, Hongjun Zheng3, Marc J Brouillette1, Douglas C Fredericks1, Emily B Petersen1, Ino Song4, Leela R J Chakka5, Aliasger K Salem5, James A Martin4,5.   

Abstract

Lubricin, a glycoprotein encoded by the proteoglycan 4 (PRG4) gene, is an essential boundary lubricant that reduces friction between articular cartilage surfaces. The loss of lubricin subsequent to joint injury plays a role in the pathogenesis of posttraumatic osteoarthritis. In this study, we describe the development and evaluation of an adeno-associated virus (AAV)-based PRG4 gene therapy intended to restore lubricin in injured joints. The green fluorescent protein (GFP) gene was inserted the PRG4 gene to facilitate tracing the distribution of the transgene product (AAV-PRG4-GFP) in vivo. Transduction efficiency of AAV-PRG4-GFP was evaluated in joint cells, and the conditioned medium containing secreted PRG4-GFP was used for shear loading/friction and viability tests. In vivo transduction of joint tissues following intra-articular injection of AAV-PRG4-GFP was confirmed in the mouse stifle joint in a surgical model of destabilization of the medial meniscus (DMM), and chondroprotective activity was tested in a rabbit anterior cruciate ligament transection (ACLT) model. In vitro studies showed that PRG4-GFP has lubricin-like cartilage-binding and antifriction properties. Significant cytoprotective effects were seen when cartilage was soaked in PRG4-GFP before cyclic shear loading (n = 3). Polymerase chain reaction and confocal microscopy confirmed the presence of PRG4-GFP DNA and protein, respectively, in a mouse DMM (n = 3 per group). In the rabbit ACLT model, AAV-PRG4-GFP gene therapy enhanced lubricin expression (p = 0.001 vs. AAV-GFP: n = 7-14) and protected the cartilage from degeneration (p = 0.014 vs. AAV-GFP: n = 9-10) when treatments were administered immediately postoperation, but efficacy was lost when treatment was delayed for 2 weeks. AAV-PRG4-GFP gene therapy protected cartilage from degeneration in a rabbit ACLT model; however, data from the ACLT model suggest that early intervention is essential for efficacy.

Entities:  

Keywords:  adeno-associated virus; friction coefficient; gene therapy; lubricin; posttraumatic osteoarthritis; proteoglycan 4

Mesh:

Substances:

Year:  2022        PMID: 34610749      PMCID: PMC9142765          DOI: 10.1089/hum.2021.177

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   4.793


  41 in total

1.  Lubrication of animal joints. II. The mechanism.

Authors:  F C Linn
Journal:  J Biomech       Date:  1968-08       Impact factor: 2.712

Review 2.  Recombinant adeno-associated virus transduction and integration.

Authors:  Brian R Schultz; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2008-05-20       Impact factor: 11.454

3.  The influence of continuous sliding and subsequent surface wear on the friction of articular cartilage.

Authors:  H Forster; J Fisher
Journal:  Proc Inst Mech Eng H       Date:  1999       Impact factor: 1.617

4.  Influence of the meniscus on friction and degradation of cartilage in the natural knee joint.

Authors:  L McCann; E Ingham; Z Jin; J Fisher
Journal:  Osteoarthritis Cartilage       Date:  2009-03-10       Impact factor: 6.576

5.  The influence of loading time and lubricant on the friction of articular cartilage.

Authors:  H Forster; J Fisher
Journal:  Proc Inst Mech Eng H       Date:  1996       Impact factor: 1.617

6.  Age-dependent Changes in the Articular Cartilage and Subchondral Bone of C57BL/6 Mice after Surgical Destabilization of Medial Meniscus.

Authors:  Henry Huang; Jordan D Skelly; David C Ayers; Jie Song
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

7.  Sex Specific Determinants in Osteoarthritis: A Systematic Review of Preclinical Studies.

Authors:  Deyanira Contartese; Matilde Tschon; Monica De Mattei; Milena Fini
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

8.  Efficacy Evaluation of a New Hyaluronan Derivative HYADD® 4-G to Maintain Cartilage Integrity in a Rabbit Model of Osteoarthritis.

Authors:  Pierre Mainil-Varlet; Antonella Schiavinato; Murielle Marie Ganster
Journal:  Cartilage       Date:  2013-01       Impact factor: 4.634

Review 9.  The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis.

Authors:  Ewa M Roos; L Stefan Lohmander
Journal:  Health Qual Life Outcomes       Date:  2003-11-03       Impact factor: 3.186

10.  The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery.

Authors:  Donald S Anson
Journal:  Genet Vaccines Ther       Date:  2004-08-13
View more
  3 in total

1.  Gene Therapy and the Use of Animal Models: Why Mice Alone Are Not Sufficient.

Authors:  Alisha M Gruntman; Terence R Flotte
Journal:  Hum Gene Ther       Date:  2022-05       Impact factor: 4.793

2.  Quadruped Gait and Regulation of Apoptotic Factors in Tibiofemoral Joints following Intra-Articular rhPRG4 Injection in Prg4 Null Mice.

Authors:  Daniel S Yang; Edward E Dickerson; Ling X Zhang; Holly Richendrfer; Padmini N Karamchedu; Gary J Badger; Tannin A Schmidt; Alger M Fredericks; Khaled A Elsaid; Gregory D Jay
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

3.  Functionalized Nanogels with Endothelin-1 and Bradykinin Receptor Antagonist Peptides Decrease Inflammatory and Cartilage Degradation Markers of Osteoarthritis in a Horse Organoid Model of Cartilage.

Authors:  Aurélie Cullier; Frédéric Cassé; Seng Manivong; Romain Contentin; Florence Legendre; Aracéli Garcia Ac; Pierre Sirois; Gaëlle Roullin; Xavier Banquy; Florina Moldovan; Lélia Bertoni; Fabrice Audigié; Philippe Galéra; Magali Demoor
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.